Literature DB >> 23874078

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa.

Ts Oluleye1, Y Babalola.   

Abstract

BACKGROUND: Idiopathic polypoidal choroidal vasculopathy is an abnormal choroidal vascular pathology similar to age-related macular degeneration. It may present with sudden visual loss from hemorrhagic retinal pigment epithelial detachment and breakthrough vitreous hemorrhage or with chronic recurrent episodes. The condition is not uncommon in the retina clinic at the University College Hospital, Ibadan, Sub-Saharan Africa. This study presents the pattern of presentation in Ibadan.
METHODS: We review all cases of idiopathic polypoidal choroidal vasculopathy seen from 2007 to 2012 in the retina clinic at the University College Hospital, Ibadan, to determine the major pattern of presentations, available treatment modalities, and visual outcomes.
RESULTS: Ten cases were seen during the study period. Their mean age was 58 years, with a male to female ratio of 1:4. The most common presenting complaint was sudden visual loss. Major examination findings were retinal pigment epithelial detachment, orange subretinal lesions, and breakthrough vitreous hemorrhage. The modalities of treatment available included vitrectomy to clear vitreous hemorrhage. Intravitreal bevacizumab reduced the height of the pigment epithelial detachment and cleared vitreous hemorrhage. Thermal laser was applied for extrafoveal lesions. Two patients with subfoveal lesions were referred abroad for photodynamic therapy. Visual outcome showed significant improvement in vitrectomized patients who presented with vitreous hemorrhage. Presenting vision of hand motion and light perception improved to vision ranging from counting fingers to 6/12 after vitrectomy.
CONCLUSION: Idiopathic polypoidal choroidal vasculopathy may not be uncommon in Sub-Saharan Africa. A high index of suspicion is warranted in the diagnosis so as to provide timely intervention.

Entities:  

Keywords:  Sub-Saharan Africa; idiopathic polypoidal choroidal vasculopathy; presentations; retinal pigment epithelial detachment

Year:  2013        PMID: 23874078      PMCID: PMC3711879          DOI: 10.2147/OPTH.S47511

Source DB:  PubMed          Journal:  Clin Ophthalmol        ISSN: 1177-5467


Introduction

Idiopathic polypoidal choroidal vasculopathy (IPCV) is a choroidal vascular abnormality characterized by sudden visual loss from macular hemorrhage or breakthrough vitreous hemorrhage. Exudation is also common. The condition was often confused with wet age-related macular degeneration until Yannuzzi et al1,2 described it as a separate entity. Early reports described in Asians and patients of dark skin race showed a female preponderance, a younger age, an association with systemic hypertension, and presentation of orange retinal lesions and subretinal hemorrhagic detachment,3,4 but to the best of the authors’ knowledge, not in Sub-Saharan Africans. This study describes the patterns of presentation in ten patients diagnosed with IPCV in Ibadan, Sub-Saharan Africa.

Materials and methods

A retrospective review was done of 10 patients seen in the retina clinic at the Department of Ophthalmology, University College Hospital, Ibadan between 2007 and 2012. The retina register was opened in 2007 after subspecialization in the Department of Ophthalmology at this hospital. Case files of patients with a diagnosis of IPCV vasculopathy were retrieved and studied. The diagnosis was based on clinical findings of subretinal orange lesions, retinal pigment epithelial detachments, subretinal hemorrhagic detachments, and exudates in the absence of drusen, as described in previous reports.1–4 Information extracted from the case file included patient demographics, presenting complaints, and visual acuity. Others included fundus findings, treatment modalities, and visual outcome at 3 months. The data were analyzed as proportions and percentages.

Results

The results are summarized in Table 1.
Table 1

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan

PatientAge (years)GenderPresentationPresenting VA (R and L)Retina signsTreatmentOutcome VA (R and L)
168FSudden visual lossR, 6/36; L, 6/60Peripheral exudates, bilateralR, 6/36; L, 6/60
247FSudden visual lossR, LP; L, 6/24VH, bilateralR vitrectomyR, CF; L, HM
347FSudden visual lossR, HM; L, LPUnilateral VHR, vitrectomyR, 6/24; L, LP
455FSudden visual lossR, CF; L, 6/9VH, RPE detached bilaterallyR, vitrectomy L, AvastinR, 6/12; L, 6/36
567FSudden visual lossR, 6/36; L, HMBilateral VH, RPE detachment, scarred maculaL, AvastinR, HM; L, CF
659MSudden visual lossR, HM; L, NLPUnilateral VHVitrectomyR, CF; L, NLP
763MSudden visual lossR, HM; L, NLPUnilateral VH Scar, orange lesionVitrectomy PDTR, CF; L, LP
856FRecurrent sudden visual lossR, HM; L, 6/60Bilateral RPE detachment, Subretinal hemorrhage. R, macular scar, orange lesionBevacizumab PDTR, CF; L, 6/60
954FSudden visual lossR, 6/9; L, 6/5Unilateral extrafoveal orange lesions, hemorrhage, RPE detachmentBevacizumab, focal laserR, 6/9; L, 6/5
1063FSudden bilateral visual lossR, HM; L, CFOrange lesions, RPE detachment, macular exudatesBevacizumabR, CF; L, CF

Abbreviations: R, right; L, left; HM, hand motion; CF, count fingers; LP, light perception; NLP, nil light perception; PDT, photodynamic therapy; RPE, retinal pigment epithelium; VH, vitreous hemorrhage; VA, visual acuity.

Discussion

Idiopathic polypoidal choroidal vasculopathy was described by Yannuzzi et al in hypertensive African Americans with hemorrhagic retinal pigment epithelial detachment in the absence of drusen.1 The present study showed a female preponderance (male to female ratio, 1:4) in the fifth and sixth decades, in keeping with previous reports of younger age than in patients with age-related macular degeneration.4 In a previous report from our center, a total of 768 retinal cases were seen in the hospital over a 3-year period, of which 101 were diagnosed to have age-related macular degeneration, representing 14% of all retinal cases seen. The peak age was at least 60 years, and the male to female ratio was about 2:3. Wet age-related macular degeneration was seen in 40 (40%) of cases. More females presented with wet age-related macular degeneration (26% versus 14%) and the intermediate form, while more males appeared to present with advanced dry age-related macular degeneration (12% versus 5%).5 Sudden visual loss was the commonest presentation in the present study. Bilateral disease occurs in about 70% of the cases. The main findings included breakthrough vitreous hemorrhage, subretinal orange lesions, and hemorrhagic retinal pigment epithelial detachment with subretinal exudates and blood. The natural course (Figures 1, 2, and 3) of the disease includes chronic serosanguinous detachment with preservation of vision. Other patients had hemorrhagic foveal detachment or chronic macular degeneration resulting in profound visual loss. The presentation usually is that of sudden visual loss, some (Figure 2) with a chronic course, some with recurrences, and 50% with favorable visual outcomes.4,6
Figure 1

Idiopathic polypoidal choroidal vasculopathy with chronic subretinal exudate in a 68-year-old woman (patient 1).

Figure 2

Fundus findings in patient 8 with idiopathic polypoidal choroidal vasculopathy. Right eye (A) with resolved subretinal blood and macular degeneration. (A) subretinal orange lesions (medium arrow); The left eye (B) shows fresh subretinal hemorrhage (long arrow); and (C) retinal pigment epithelial detachment (short arrow). Note the absence of drusen seen in age-related macular degeneration.

Figure 3

Patient 10 with idiopathic polypoidal choroidal vasculopathy. Orange subretinal lesion (long arrow) and subretinal exudates (short arrow).

Idiopathic polypoidal choroidal vasculopathy is characterized by vascular aneurysmal lesions with interconnecting branches of vessels terminating in polyps. These polyps are prone to developing multiple, recurrent, serosanguinous retinal pigment epithelial detachment and neurosensory retinal detachment due to leakage and/or hemorrhage from the abnormal choroidal vascular lesions.1,2,4 Reported retinal findings include hemorrhagic detachment in about 75% and exudative findings in 25%.6 The present study showed hemorrhagic detachment in about 90% of cases, with breakthrough vitreous hemorrhage in 50% of cases. The diagnosis of IPCV should be suspected in the presence of hemorrhagic or exudative retinal pigment epithelial detachments in the absence of drusen. However, the definitive diagnosis is established using indocyanine green angiography. This demonstrates the branching vascular network originating from choroidal circulation terminating in aneurysmal dilatation. Indocyanine green angiography uses infrared rays, hence its ability to detect the lesion under blood as opposed to fundus fluorescein angiography.7 Indocyanine green angiography studies showed two types of aneurysmal dilatation, ie, the solitary lesion and clusters resembling grapes. The latter is associated with recurrent bleeding and a poor visual prognosis.3 Indocyanine green angiography and optical coherence tomography are not available in our center, so the diagnosis was based on clinical findings. Treatment modalities for IPCV include observation for extrafoveal lesions. Thermal laser is suggested for extrafoveal lesions threatening the fovea. Photodynamic therapy has been reported to be effective for subfoveal lesions by causing occlusion of the abnormal choroidal vasculature with improvement in vision.8–14 In the present study, vitrectomy was performed to clear breakthrough vitreous hemorrhage with improvement in vision. Intravitreal bevacizumab helped in clearing vitreous hemorrhage and reducing the height of pigment epithelial detachment. Intravitreal bevacizumab has been demonstrated to be beneficial in IPCV.15 Two of our patients were referred abroad for photodynamic therapy. Visual outcome in the present study showed significant improvement in vitrectomized patients with vitreous hemorrhage. Presenting vision of hand motion and light perception improved to vision ranging from counting fingers at one meter to 6/12 after vitrectomy. Intravitreal bevacizumab was administered to five patients and found to stabilize vision.

Conclusion

IPCV is not uncommon in Ibadan, Sub-Saharan Africa. Patients presenting with sudden visual loss, vitreous hemorrhage, retinal pigment epithelial detachment, and subretinal exudation in the absence of drusen, should raise an index of suspicion in ophthalmologists in Sub-Saharan Africa.
  14 in total

1.  Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.

Authors:  M Mauget-Faÿsse; M Quaranta-El Maftouhi; E De La Marnièrre; A Leys
Journal:  Eur J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.597

2.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

3.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients.

Authors:  M Uyama; T Matsubara; I Fukushima; H Matsunaga; K Iwashita; Y Nagai; K Takahashi
Journal:  Arch Ophthalmol       Date:  1999-08

4.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

5.  Role of photodynamic therapy in polypoidal choroidal vasculopathy.

Authors:  Nazimul Hussain; Anjli Hussain; Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2005-06       Impact factor: 1.848

6.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

7.  Photodynamic therapy of polypoidal choroidal vasculopathy.

Authors:  Adam H Rogers; Paul B Greenberg; Adam Martidis; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2003 Jan-Feb

8.  Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.

Authors:  Maddalena Quaranta; Martine Mauget-Faÿsse; Gabriel Coscas
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

9.  Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy.

Authors:  T Y Y Lai; W-M Chan; D T L Liu; F O J Luk; D S C Lam
Journal:  Br J Ophthalmol       Date:  2008-03-20       Impact factor: 4.638

10.  Is age-related macular degeneration a problem in Ibadan, Sub-Saharan Africa?

Authors:  Tunji Sunday Oluleye
Journal:  Clin Ophthalmol       Date:  2012-04-11
View more
  4 in total

1.  Polypoidal Choroidal Vasculopathy in Congolese Patients.

Authors:  Nelly N Kabedi; David L Kayembe; Gloria M Elongo; Jean-Claude Mwanza
Journal:  J Ophthalmol       Date:  2020-01-18       Impact factor: 1.909

2.  Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps.

Authors:  Jae Hui Kim; Dong Won Lee; Sung Chan Choi; Jong Woo Kim; Tae Gon Lee; Chul Gu Kim; Han Joo Cho
Journal:  Korean J Ophthalmol       Date:  2015-11-25

3.  Indications for intravitreal bevacizumab in ibadan, sub-saharan Africa.

Authors:  Oluleye T S; Babalola Y
Journal:  Open Ophthalmol J       Date:  2014-11-28

4.  Profile, Visual Presentation and Burden of Retinal Diseases Seen in Ophthalmic Clinics in Sub-Saharan Africa.

Authors:  Dennis Nkanga; Olukorede Adenuga; Ogugua Okonkwo; Wilson Ovienria; Affiong Ibanga; Chineze Agweye; Idris Oyekunle; Toyin Akanbi
Journal:  Clin Ophthalmol       Date:  2020-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.